SASTASUNDAR VENTURES: Q3 CONS NET PROFIT 11M RUPEES VS LOSS 269M (YOY) || Q3 REVENUE 3.46B RUPEES VS 2.8B (YOY)

Aurobindo Pharma: US FDA Inspects Eugia Pharma Unit-III, Finds 11 Procedural Issues

RAM RATNA WIRES: Q3 EBITDA 720M RUPEES VS 390M (YOY) || Q3 EBITDA MARGIN 5.64% VS 4.38% (YOY)

RAM RATNA WIRES: Q3 CONS NET PROFIT 313M RUPEES VS 181M (YOY) || Q3 REVENUE 12.8B RUPEES VS 8.8B (YOY)

SUDEEP PHARMA: Q3 EBITDA 600M RUPEES VS 393M (YOY) || Q3 EBITDA MARGIN 34.80% VS 34.01% (YOY)

SUDEEP PHARMA: Q3 CONS NET PROFIT 475M RUPEES VS 287M (YOY) || Q3 REVENUE 1.7B RUPEES VS 1.15B (YOY)

GUJARAT ALKALIES: Q3 PROFIT BEFORE EXCEPTIONAL ITEM 126M RUPEES VS 45M (YOY) || CO HAS EXCEPTIONAL ITEM OF 88M RUPEES AND DEFERRED TAX OF 259M RUPEES

GUJARAT ALKALIES: Q3 EBITDA 1.04B RUPEES VS 980M (YOY) || Q3 EBITDA MARGIN 10.03% VS 9.52% (YOY)

GUJARAT ALKALIES: Q3 CONS NET LOSS 199.5M RUPEES VS LOSS 112M (YOY) || Q3 REVENUE 10.5B RUPEES VS 10.3B (YOY)

MEDI ASSIST HEALTHCARE SERVICES: Q3 EBITDA 446M RUPEES VS 397M (YOY) || Q3 EBITDA MARGIN 18.61% VS 21.34% (YOY)

MEDI ASSIST HEALTHCARE SERVICES: Q3 CONS NET PROFIT 42M RUPEES VS 295M (YOY) || Q3 REVENUE 2.4B RUPEES VS 1.86B (YOY)

BEST AGROLIFE: Q3 EBITDA 10M RUPEES VS 40M (YOY) || Q3 EBITDA MARGIN 0.78% VS 2.07% (YOY)

BEST AGROLIFE: Q3 SL NET LOSS 58M RUPEES VS LOSS 61M (YOY) || Q3 REVENUE 1.3B RUPEES VS 1.9B (YOY)

BALMER LAWRIE & COMPANY: Q3 EBITDA 863M RUPEES VS 839M (YOY) || Q3 EBITDA MARGIN 13.13% VS 13.31% (YOY)

BALMER LAWRIE & COMPANY: Q3 CONS NET PROFIT 666M RUPEES VS 644M (YOY) || Q3 REVENUE 6.6B RUPEES VS 6.3B (YOY)

DISH TV INDIA: Q3 EBITDA LOSS 415M RUPEES VS GAIN 1.2B (YOY)

DISH TV INDIA: Q3 CONS NET LOSS 2.76B RUPEES VS LOSS 465M (YOY) || Q3 REVENUE 3B RUPEES VS 3.7B (YOY)